ADCETRIS 50 mg, powder for concentrate for infusion bottle

Telegram WhatsApp

Link to share

Active ingredients: BRENTUXIMAB VÉDOTINE

Commercialized according to BDPMDispensing in France: Prescription only, hospital use

Powder for concentrate for infusionbottleintraveineuse

No current ANSM shortage notice is included

Package details

Original BDPM fields are shown in French.

Official name: ADCETRIS 50 mg, poudre pour solution à diluer pour perfusion
Pharmaceutical form: poudre pour solution à diluer pour perfusion
Route of administration: intraveineuse
Presentation description: 1 flacon(s) en verre
Marketing authorisation holder: TAKEDA PHARMA (DANEMARK)
Reimbursement according to BDPM: —
Approval for use in healthcare institutions: oui
Commercialization declaration date: 18 Mar 2013
Prescription and dispensing conditions: Prescription only, hospital use
List I: prescription-only medicine
Requires special monitoring during treatment
Prescribed by specialists only
Hospital use only
Original BDPM wording: liste I · médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux médecins compétents en CANCEROLOGIE · prescription réservée aux médecins compétents en maladie du sang · prescription réservée aux spécialistes et services HEMATOLOGIE · prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE · réservé à l'usage HOSPITALIER
Enhanced ANSM monitoring: No

BDPM identifiers

CIS68438457CIP75839718CIP133400958397189

Composition in BDPM

Composition in BDPM
Component	Amount per unit	Source type
BRENTUXIMAB VÉDOTINEpoudre	50 mg · un flacon	SA

Information is based on BDPM data and is for reference only. Consult a doctor before use.

Similar medicines

Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.

The current BDPM data does not list similar medicines for this product.